IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q3 2016 Holdings

Filed 2016-11-14 | 17 holdings | $13.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Conmed Corp(CNMD)COM207410101$13.1M325,78598.0%
United Therapeutics Corp(UTHR)COM91307C102$32.6K275,7640.2%
Orthofix International NVCOMN6748L102$27.4K639,8510.2%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$26.6K999,7410.2%
Impax Laboratories IncCOM45256B101$24.5K1,032,1870.2%
Amgen IncCOM31162100$21.0K126,0380.2%
Sucampo Pharmaceuticals CL ACOM864909106$20.3K1,651,8980.2%
Halyard Health IncCOM40650V100$20.0K576,2850.1%
Indivior PLCCOMG4766E108$18.8K4,736,8230.1%
Teva Pharmaceutical SP ADR(TEVA)COM881624209$18.3K397,4120.1%
Merck & Co Inc(MRK)COM58933Y105$16.1K258,0210.1%
RTI Surgical IncCOM74975N105$13.1K4,181,0910.1%
Invacare CorpCOM461203101$11.7K1,043,1110.1%
Aviragen Therapeutics IncCOM53761102$5.2K2,713,5170.0%
Derma Sciences IncCOM249827502$4.1K884,0000.0%
Digirad CorpCOM253827109$2.5K482,1210.0%
Juniper Pharmaceuticals IncCOM48203L107$1.6K288,2940.0%